2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 238

Power Dopper Ultrasonography Detects Superior Efficacy of Non-TNF Biologics Compared to Cycling of TNF Inhibitors in RA Patients Inadequate Response to First TNF Inhibitors
Abstract Number: 239

Ultrasound Abnormalities Predict Arthritis Development in ACPA and/or RF Positive Arthralgia Patients
Abstract Number: 240

Finger Joint Cartilage Thickness Evaluated By Semiquantitative Ultrasound Score in Patients with Rheumatoid Arthritis
Abstract Number: 241

Histological and Clinical Correlates of Ultrasound Measures of Joint Inflammation: Analysis of RA Tissue Obtained By Ultrasound Guided Biopsy in Phase 1 of the Accelerating Medicines Partnership RA Network
Abstract Number: 242

Evaluation of Bone Erosions in Rheumatoid Arthritis Patients Using Cone Beam Computed Tomography, Magnetic Resonance Imaging, and Ultrasound
Abstract Number: 243

Tracer Uptake from High Resolution Bone SPECT/CT Is Linked to Response in Rheumatoid Arthritis Patients
Abstract Number: 244

Rheumatoid Arthritis Imaging on PET-CT Using a Novel Folate Receptor Ligand for Macrophage Targeting
Abstract Number: 245

The Clinical Utility of Splenic Fluorodeoxyglucose Uptake for Diagnosis and Prognosis in Patients with Macrophage Activation Syndrome
Abstract Number: 246

Development and Validation of a Flourescence Optical Imaging Rheumatoid Arthritis Scoring System for Synovitis in the Wrist and Hand
Abstract Number: 247

Near Infrared Indocyanine Green Imaging Reveals Diminished Flow in Basilic Associated Lymphatic Vessels in the Hands of Rheumatoid Arthritis Patients during Flare
Abstract Number: 248

Validation of Objective Quantification System for Disease Progression in Patients with Juvenile Idiopathic Arthritis
Abstract Number: 249

Where to Look for Uric Acid Crystals? Results from a Norwegian Ultrasound Study
Abstract Number: 250

An Ultrasonographic Study for Investigating Relationships with the Signs of Uric Deposition and Bone Erosion in Patients with Hyperuricemia
Abstract Number: 251

Articular Cartilage of Knee and First MTP Joint Are the Preferred Sites of Urate Crystal Deposition in Asymptomatic Hyperuricemic Individuals
Abstract Number: 252

Correlations between Clinical and Ultrasound Scores of Peripheral Enthesitis and Disease Activity Scores in a Cohort of Spondyloarthritis

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].